MedPath

To see the effect of Herbo mineral and modified Herbo mineral drug in the management of constipatio

Phase 1
Conditions
Health Condition 1: K590- Constipation
Registration Number
CTRI/2024/07/071097
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients meeting the Rome III diagnostic criteria for functional constipation ? [patients presenting with two or more of the following for the last three months with symptom onset at least six months prior to diagnosis:

(a) Straining during at least 25% of defecations,

(b) Lumpy or hard stools at least 25% of defecations,

(c) Sensation of incomplete evacuation at least 25% of defecations,

(d) Sensation of anorectal obstruction/blockage at least 25% of defecations,

(e) Manual maneuvers to facilitate at least 25% of defecations, e.g., digital evacuation, support of the pelvic floor,

(f) Fewer than three defecations per week and those in whom loose stools are rarely present without the use of laxatives will be included.

Patients with a stool form score ranging from 1 to 3 on the Bristol Stool Form Scale ? will be included.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in FC symptoms in constipation questionnaire. [Timeline: baseline (0 week), 2-week] <br/ ><br>Changes in symptoms of Vibandha disease. [Timeline: baseline (0 week), 2-week] <br/ ><br>Timepoint: 52 weeks
Secondary Outcome Measures
NameTimeMethod
Changes in QOL in FC patients by, Patients Assessment of Constipation Quality of LifeTimepoint: 48 weeks
© Copyright 2025. All Rights Reserved by MedPath